Funding Rounds
Shorla Pharma

Shorla Pharma Series B (2023, $35M)

Shorla Pharma

Oncology treatment plalform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $35.00M

Raised Date: 2023-04-01

Investors